#drug-development
Documents
The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases
Aucun résultat à afficher.
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
{{productIsPremium}}
{{productCategoryLabel}}
{{productTitle}}
{{productIsPremium}}
{{productCategoryLabel}}
{{productThemeLabel}}
{{productTitle}}
{{productPages}}
{{productLanguageIsoCode}}
{{sortLabel}}
{{sortLabel}}